| 000 | 01823 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517042640.0 | ||
| 264 | 0 | _c20151124 | |
| 008 | 201511s 0 0 eng d | ||
| 022 | _a1535-5667 | ||
| 024 | 7 |
_a10.2967/jnumed.115.155929 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKiess, Ana P | |
| 245 | 0 | 0 |
_aAuger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen. _h[electronic resource] |
| 260 |
_bJournal of nuclear medicine : official publication, Society of Nuclear Medicine _cSep 2015 |
||
| 300 |
_a1401-1407 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aApoptosis _xradiation effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xradiation effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIodine Radioisotopes _xpharmacokinetics |
| 650 | 0 | 4 |
_aKallikreins _xmetabolism |
| 650 | 0 | 4 |
_aLysine _xanalogs & derivatives |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMolecular Targeted Therapy _xmethods |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xmetabolism |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xpathology |
| 650 | 0 | 4 | _aRadiation Dosage |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xpharmacokinetics |
| 650 | 0 | 4 |
_aRadiotherapy _xmethods |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUrea _xanalogs & derivatives |
| 700 | 1 | _aMinn, Il | |
| 700 | 1 | _aChen, Ying | |
| 700 | 1 | _aHobbs, Robert | |
| 700 | 1 | _aSgouros, George | |
| 700 | 1 | _aMease, Ronnie C | |
| 700 | 1 | _aPullambhatla, Mrudula | |
| 700 | 1 | _aShen, Colette J | |
| 700 | 1 | _aFoss, Catherine A | |
| 700 | 1 | _aPomper, Martin G | |
| 773 | 0 |
_tJournal of nuclear medicine : official publication, Society of Nuclear Medicine _gvol. 56 _gno. 9 _gp. 1401-1407 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2967/jnumed.115.155929 _zAvailable from publisher's website |
| 999 |
_c25082135 _d25082135 |
||